Also, regulatory T cells (Tregs) are committed to survive and proliferate in such a hostile milieu like tumor microenvironment because they display and exploit both glycolysis and fatty acid synthesis/oxidation, allowing them to predominate over CD4/CD8+ T cells mainly relying on the glycolysis (45). The gene discussed is CD8A; the disease is neoplasm.